PROF vs PSA · rev $10.7M vs rev $4.82B
Profound Medical Corp (PROF) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
PROF currently screens at market cap $238.7M. PSA currently screens at market cap $0.
Not investment advice. Open the PROF and PSA stock pages for the full models.
Not investment advice.